Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Xenetic Biosciences Inc (XBIO)

Xenetic Biosciences Inc (XBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Xenetic Dips on Full-Year Results

Xenetic Biosciences, Inc. (NASDAQ:XBIO) shares began Friday negative, as the company, based out of Framingham, ...

XBIO : 4.14 (-3.84%)
Xenetic Biosciences: Q3 Earnings Snapshot

Xenetic Biosciences: Q3 Earnings Snapshot

XBIO : 4.14 (-3.84%)
Xenetic Biosciences, Inc. Reports Third Quarter 2023 Financial Results

FRAMINGHAM, MA / ACCESSWIRE / November 10, 2023 / Xenetic Biosciences, Inc. (NASDAQ:XBIO) ("Xenetic" or the "Company"), a biopharmaceutical company focused on advancing innovative immune-oncology technologies...

XBIO : 4.14 (-3.84%)
JTC Team Announces Presenting Company Line Up for the Virtual Investor “Ask the CEO” Conference Being Held October 24-25, 2023

- Live video webcast interactive Q&A with participating companies -

EVFM : 0.0139 (-0.71%)
GRI : 0.4207 (-0.80%)
MBRX : 5.06 (+0.80%)
XBIO : 4.14 (-3.84%)
AREC : 1.5100 (+3.42%)
CNSP : 0.2180 (+3.12%)
NVNO : 5.13 (-3.21%)
PALI : 6.70 (-5.37%)
Xenetic Biosciences, Inc. to Participate at the Virtual Investor Ask the CEO Conference

Live moderated webcast with Jeffrey Eisenberg, Chief Executive Officer of Xenetic Biosciences on Tuesday, October 24th at 1:00 PM ET

XBIO : 4.14 (-3.84%)
Xenetic Biosciences: Q2 Earnings Snapshot

Xenetic Biosciences: Q2 Earnings Snapshot

XBIO : 4.14 (-3.84%)
Xenetic Biosciences: Q1 Earnings Snapshot

Xenetic Biosciences: Q1 Earnings Snapshot

XBIO : 4.14 (-3.84%)
Esperion Therapeutics (ESPR) Reports Q1 Loss, Tops Revenue Estimates

Esperion Therapeutics (ESPR) delivered earnings and revenue surprises of -21.54% and 15.71%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

ESPR : 2.10 (+2.94%)
XBIO : 4.14 (-3.84%)
Collegium Pharmaceutical (COLL) Q1 Earnings Meet Estimates

Collegium Pharmaceutical (COLL) delivered earnings and revenue surprises of 0% and 4.07%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

COLL : 37.78 (+2.30%)
XBIO : 4.14 (-3.84%)
Journey Medical Corporation (DERM) Reports Q3 Loss, Misses Revenue Estimates

Journey Medical Corporation (DERM) delivered earnings and revenue surprises of -67.65% and 11.59%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the...

DERM : 3.51 (-4.88%)
XBIO : 4.14 (-3.84%)

Barchart Exclusives

Bill Gross: If You Must Buy Tech Stocks, This One Is the Best
'Bond King' Bill Gross has just given the green light to this tech giant. With its dominant market position and impressive recent earnings report, the stock is well-loved by analysts, too. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar